Actively Recruiting

Phase 3
Age: 19Years +
All Genders
NCT07488611

PROGAIN Trial in Gastric Cancer Surgery

Led by Soonchunhyang University Hospital · Updated on 2026-03-25

100

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

Sponsors

S

Soonchunhyang University Hospital

Lead Sponsor

J

JW Pharmaceutical

Collaborating Sponsor

AI-Summary

What this Trial Is About

This randomized study will evaluate whether protein-enriched parenteral nutrition improves early postoperative recovery in patients undergoing gastrectomy for gastric cancer. Participants will be assigned to receive either protein-enriched parenteral nutrition or standard parenteral nutrition during the perioperative period. The primary outcome is nitrogen balance on postoperative day 5. Secondary outcomes include postoperative complications, recovery of oral intake, and short-term changes in nutritional status and body composition.

CONDITIONS

Official Title

PROGAIN Trial in Gastric Cancer Surgery

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 19 years or older scheduled to undergo gastric cancer surgery
  • Patients who have provided written informed consent to participate in this study
Not Eligible

You will not qualify if you...

  • Patients with uncontrolled severe systemic diseases such as decompensated diabetes, cerebrovascular event within the last 6 months, sepsis, or heart failure
  • Patients who have received intravenous parenteral nutrition within 7 days prior to randomization
  • Patients with severe metabolic abnormalities confirmed by preoperative lab tests, including triglyceride > 400 mg/dL, AST or ALT > 3 x Upper Limit of Normal, total bilirubin > 3 x Upper Limit of Normal, serum creatinine > 2 x Upper Limit of Normal, HbA1c > 9.0%, potassium < 3.0 mEq/L or > 6.0 mEq/L, calcium > 12.5 mg/dL, sodium > 155 mmol/L, or magnesium > 3.0 mg/dL
  • Patients deemed inappropriate for participation by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Soonchunhyang University Cheonan Hospital

Cheonan, Chungcheongnam-do, South Korea, 31151

Actively Recruiting

Loading map...

Research Team

J

Jong Hyuk Yun, MD, PhD

CONTACT

H

Hyun Seob Shin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here